The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Intrinsic subtypes of HER2-positive breast cancer and their associations with pathologic complete response (pCR) and outcomes: Findings from NSABP B-41, a randomized neoadjuvant trial.
 
Sandra M. Swain
Honoraria - Novartis; Roche
Consulting or Advisory Role - Genentech/Roche; Inivata; Lilly; Pieris Pharmaceuticals
Research Funding - Genentech (Inst); Lilly (Inst); Merrimack; Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Caris Centers of Excellence; Genentech/Roche; Inivata
Other Relationship - AstraZeneca
 
Gong Tang
Consulting or Advisory Role - ExxonMobile Biomedical Sciences
 
Peter C. Lucas
Stock and Other Ownership Interests - Amgen
 
Andre Robidoux
Consulting or Advisory Role - AstraZeneca; Genomic Health; Novartis; Pfizer
Research Funding - AstraZeneca; Merck
 
David Goerlitz
No Relationships to Disclose
 
Brent T. Harris
No Relationships to Disclose
 
Hanna Bandos
No Relationships to Disclose
 
Charles E. Geyer
Consulting or Advisory Role - Celgene; HERON; Myriad Genetics
Research Funding - Merck
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Genentech/Roche
 
Priya Rastogi
No Relationships to Disclose
 
Eleftherios P. Mamounas
Honoraria - Genentech/Roche; Genomic Health
Consulting or Advisory Role - bioTheranostics; Celcuity; Genomic Health; GRAIL; Macrogenics
Speakers' Bureau - Genentech/Roche; Genomic Health
Travel, Accommodations, Expenses - Celgene; Genentech/Roche; Genomic Health
 
Norman Wolmark
Research Funding - AbbVie (Inst); AbbVie (Inst); Bayer (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Puma Biotechnology (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - AbbVie (Inst)
Travel, Accommodations, Expenses - Abbvie; AbbVie; Genentech; GHI Pharma; Sanofi